IGF-Binding Proteins and Their Proteolysis as a Mechanism of Regulated IGF Release in the Nervous Tissue

[1]  Zhiqiang Meng,et al.  Insulin growth factor-1 promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through the Wnt/β-catenin pathway , 2021, Experimental and therapeutic medicine.

[2]  D. Kaufer,et al.  Hormonal Regulation of Oligodendrogenesis I: Effects across the Lifespan , 2021, Biomolecules.

[3]  A. Araque,et al.  IGF-I Governs Cortical Inhibitory Synaptic Plasticity By Astrocyte Activation , 2020, bioRxiv.

[4]  Yingzheng Wang,et al.  IGF-1 Inhibits Apoptosis of Porcine Primary Granulosa Cell by Targeting Degradation of BimEL , 2019, International journal of molecular sciences.

[5]  S. Nef,et al.  The Insulin/IGF System in Mammalian Sexual Development and Reproduction , 2019, International journal of molecular sciences.

[6]  D. Clemmons,et al.  IRS‐1 Functions as a Molecular Scaffold to Coordinate IGF‐I/IGFBP‐2 Signaling During Osteoblast Differentiation , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  S. Koh,et al.  Glia-Like Cells from Late-Passage Human MSCs Protect Against Ischemic Stroke Through IGFBP-4 , 2019, Molecular Neurobiology.

[8]  M. Lewitt,et al.  The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System , 2019, Biochemistry insights.

[9]  A. Dale,et al.  Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer’s Disease Pathology and Shows Differential Expression in Transgenic Mice , 2018, Front. Neurosci..

[10]  F. Hakuno,et al.  IGF1 receptor signaling pathways. , 2018, Journal of molecular endocrinology.

[11]  S. Kozlovsky,et al.  Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients. , 2018, Clinical biochemistry.

[12]  M. Benito,et al.  Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis , 2018, Cardiovascular Diabetology.

[13]  Z. Kuncic,et al.  Elucidating the Activation Mechanism of the Insulin-Family Proteins with Molecular Dynamics Simulations , 2016, PloS one.

[14]  Sumei Chen,et al.  IGF-I induces adipose derived mesenchymal cell chondrogenic differentiation in vitro and enhances chondrogenesis in vivo , 2016, In Vitro Cellular & Developmental Biology - Animal.

[15]  E. Tirrò,et al.  The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy , 2015, Front. Oncol..

[16]  R. Baxter.  Nuclear actions of insulin-like growth factor binding protein-3. , 2015, Gene.

[17]  P. Marin,et al.  Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis* , 2015, The Journal of Biological Chemistry.

[18]  S. Kozlovsky,et al.  Characterization of endogenously circulating IGFBP-4 fragments-Novel biomarkers for cardiac risk assessment. , 2015, Clinical biochemistry.

[19]  Hugues Berry,et al.  Suppression of IGF-I signals in neural stem cells enhances neurogenesis and olfactory function during aging , 2015, Aging cell.

[20]  M. Koutsilieris,et al.  The role of the insulin-like growth factor-1 system in breast cancer , 2015, Molecular Cancer.

[21]  Jonas Frisén,et al.  Adult Neurogenesis in Humans- Common and Unique Traits in Mammals , 2015, PLoS biology.

[22]  Geng Chen,et al.  IGF-1 Promotes Brn-4 Expression and Neuronal Differentiation of Neural Stem Cells via the PI3K/Akt Pathway , 2014, PloS one.

[23]  R. Baxter,et al.  IGF binding proteins in cancer: mechanistic and clinical insights , 2014, Nature Reviews Cancer.

[24]  G. Werther,et al.  IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells , 2014, Oncogene.

[25]  M. Nijland,et al.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction. , 2014, Endocrinology.

[26]  R. Baxter,et al.  The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents , 2014, Oncogene.

[27]  Yujun Liu,et al.  Temporal expression patterns of insulin-like growth factor binding protein-4 in the embryonic and postnatal rat brain , 2013, BMC Neuroscience.

[28]  Yujun Liu,et al.  Temporal expression patterns of insulin-like growth factor binding protein-4 in the embryonic and postnatal rat brain , 2013, BMC Neuroscience.

[29]  M. Trajkovic-Arsic,et al.  The role of insulin and IGF system in pancreatic cancer. , 2013, Journal of molecular endocrinology.

[30]  F. Wang,et al.  Altered methylation of IGF2 DMR0 is associated with neural tube defects , 2013, Molecular and Cellular Biochemistry.

[31]  P. Stankiewicz,et al.  Intragenic deletions of the IGF1 receptor gene in five individuals with psychiatric phenotypes and developmental delay , 2013, European Journal of Human Genetics.

[32]  C. Conover,et al.  Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice. , 2013, Endocrinology.

[33]  I. Castilla-Cortázar,et al.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency , 2012, Journal of Translational Medicine.

[34]  J. O’Kusky,et al.  Neurodevelopmental effects of insulin-like growth factor signaling , 2012, Frontiers in Neuroendocrinology.

[35]  E. Ghigo,et al.  The IGF system , 2011, Acta Diabetologica.

[36]  Angel Nuñez,et al.  Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNS , 2010, Neuron.

[37]  P. Delafontaine,et al.  IGF-1, oxidative stress and atheroprotection , 2010, Trends in Endocrinology & Metabolism.

[38]  I. Torres-Aleman,et al.  Toward a comprehensive neurobiology of IGF‐I , 2010, Developmental neurobiology.

[39]  C. Overall,et al.  Multiplex N-terminome Analysis of MMP-2 and MMP-9 Substrate Degradomes by iTRAQ-TAILS Quantitative Proteomics* , 2010, Molecular & Cellular Proteomics.

[40]  D. Clemmons.  Role of IGF-I in skeletal muscle mass maintenance , 2009, Trends in Endocrinology & Metabolism.

[41]  K. Sjögren,et al.  The role of liver-derived insulin-like growth factor-I. , 2009, Endocrine reviews.

[42]  R. Baxter,et al.  Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity* , 2009, The Journal of Biological Chemistry.

[43]  David Zhang,et al.  The crosstalk between EGF, IGF, and Insulin cell signaling pathways - computational and experimental analysis , 2009, BMC Systems Biology.

[44]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[45]  T. Braulke,et al.  Multiple post-translational modifications of mouse insulin-like growth factor binding protein-6 expressed in epithelial Madin–Darby canine kidney cells , 2008, Molecular and Cellular Endocrinology.

[46]  A. Colao.  The GH–IGF‐I axis and the cardiovascular system: clinical implications , 2008, Clinical endocrinology.

[47]  Yao‐Hua Song,et al.  The anti-apoptotic effect of IGF-1 on tissue resident stem cells is mediated via PI3-kinase dependent secreted frizzled related protein 2 (Sfrp2) release. , 2008, Biochemical and biophysical research communications.

[48]  M. Kearney,et al.  The role of IGF‐I and its binding proteins in the development of type 2 diabetes and cardiovascular disease , 2008, Diabetes, obesity & metabolism.

[49]  C. Overall,et al.  Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co , 2007, Molecular and Cellular Biology.

[50]  R. Baxter,et al.  The in Vivo Phosphorylation and Glycosylation of Human Insulin-like Growth Factor-binding Protein-5 *S , 2007, Molecular & Cellular Proteomics.

[51]  C. Stewart,et al.  Apoptosis and the cardiac action of insulin-like growth factor I. , 2007, Pharmacology & therapeutics.

[52]  N. Wilczak,et al.  Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis. , 2007, Cytokine & growth factor reviews.

[53]  G. Camussi,et al.  Insulin‐like growth factor binding protein‐3 induces angiogenesis through IGF‐I‐ and SphK1‐dependent mechanisms , 2007, Journal of thrombosis and haemostasis : JTH.

[54]  R. Norton,et al.  The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs. , 2007, Biochemistry.

[55]  P. Cohen,et al.  Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis , 2007, Oncogene.

[56]  D. Leroith,et al.  Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1 , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[57]  C. Oxvig,et al.  Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5. , 2007, Molecular endocrinology.

[58]  S. Kar,et al.  Effect of kainic acid treatment on insulin-like growth factor-2 receptors in the IGF2-deficient adult mouse brain , 2007, Brain Research.

[59]  R. Norton,et al.  Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2). , 2006, Journal of molecular biology.

[60]  P. Jenkins.  Cancers Associated with Acromegaly , 2006, Neuroendocrinology.

[61]  R. Huber,et al.  Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins , 2006, Proceedings of the National Academy of Sciences.

[62]  D. Dunger,et al.  Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes , 2006, Diabetes.

[63]  P. Yin,et al.  Several Acidic Amino Acids in the N-domain of Insulin-like Growth Factor-binding Protein-5 Are Important for Its Transactivation Activity* , 2006, Journal of Biological Chemistry.

[64]  K. Conant,et al.  Myelin Formation during Development of the CNS Is Delayed in Matrix Metalloproteinase-9 and -12 Null Mice , 2006, The Journal of Neuroscience.

[65]  B. Tönshoff,et al.  Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5. , 2006, American journal of physiology. Endocrinology and metabolism.

[66]  A. Hoeflich,et al.  Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. , 2005, Endocrinology.

[67]  A. Ochiai,et al.  Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. , 2005, Biochemical and biophysical research communications.

[68]  R. Norton,et al.  IGF-binding proteins – the pieces are falling into place , 2005, Trends in Endocrinology & Metabolism.

[69]  R. Norton,et al.  C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II. , 2004, Molecular endocrinology.

[70]  L. Bach.  The insulin-like growth factor system: towards clinical applications. , 2004, The Clinical biochemist. Reviews.

[71]  P. Froment,et al.  Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproduction abnormalities. , 2004, Endocrinology.

[72]  C. Kahn,et al.  Role for neuronal insulin resistance in neurodegenerative diseases , 2004 .

[73]  H. Hansson,et al.  Rapid axoplasmic transport of insulin-like growth factor I in the sciatic nerve of adult rats , 1987, Cell and Tissue Research.

[74]  K. Jessen,et al.  Glial cells. , 2004, The international journal of biochemistry & cell biology.

[75]  C. Lautier,et al.  IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. , 2003, The New England journal of medicine.

[76]  T. Sugisaki,et al.  Actions of insulin-like growth factor binding protein-5 (IGFBP-5) are potentially regulated by tissue kallikrein in rat brains. , 2003, Life sciences.

[77]  D. Roith.  The Insulin-Like Growth Factor System , 2003, Experimental Diabesity Research.

[78]  L. Witters,et al.  Insulin‐like growth factor 1 is essential for normal dendritic growth , 2003, Journal of neuroscience research.

[79]  R. Baxter,et al.  Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. , 2003, Endocrinology.

[80]  Philippe Monget,et al.  Pregnancy-Associated Plasma Protein-A Is Involved in Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) Proteolytic Degradation in Bovine and Porcine Preovulatory Follicles: Identification of Cleavage Site and Characterization of IGFBP-2 Degradation1 , 2002, Biology of reproduction.

[81]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[82]  T. Gómez-Isla,et al.  Serum insulin-like growth factor I regulates brain amyloid-β levels , 2002, Nature Medicine.

[83]  J. Argente,et al.  Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. , 2002, Endocrinology.

[84]  Fabrice P Cordelières,et al.  The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. , 2002, Developmental cell.

[85]  J. O’Kusky,et al.  Mutant mouse models of insulin-like growth factor actions in the central nervous system , 2002, Neuropeptides.

[86]  Z. Laron,et al.  Craniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity). , 2002, European journal of endocrinology.

[87]  T. Gómez-Isla,et al.  Serum insulin-like growth factor I regulates brain amyloid-beta levels. , 2002, Nature medicine.

[88]  I. Langmoen,et al.  Depolarization induces insulin-like growth factor binding protein-2 expression in vivo via NMDA receptor stimulation. , 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[89]  E. Feldman,et al.  Insulin-like growth factor I stimulates motility in human neuroblastoma cells , 2001, Oncogene.

[90]  L. Giudice,et al.  Pregnancy‐associated plasma protein‐A (PAPP‐A) cleaves insulin‐like growth factor binding protein (IGFBP)‐5 independent of IGF: implications for the mechanism of IGFBP‐4 proteolysis by PAPP‐A , 2001, FEBS letters.

[91]  T. Holak,et al.  The interaction of insulin‐like growth factor‐I with the N‐terminal domain of IGFBP‐5 , 2001, The EMBO journal.

[92]  D. Leroith,et al.  Insulin-like Growth Factor 1 (IGF-1)-induced Twist Expression Is Involved in the Anti-apoptotic Effects of the IGF-1 Receptor* , 2001, The Journal of Biological Chemistry.

[93]  C. Conover,et al.  Pregnancy-associated Plasma Protein-A2 (PAPP-A2), a Novel Insulin-like Growth Factor-binding Protein-5 Proteinase* , 2001, The Journal of Biological Chemistry.

[94]  R. Baxter,et al.  Mutagenesis of basic amino acids in the carboxyl-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding. , 2001, Endocrinology.

[95]  L. Murphy,et al.  Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. , 2001, The Journal of clinical endocrinology and metabolism.

[96]  R. Whitehead,et al.  Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells , 2001, Molecular and Cellular Endocrinology.

[97]  K. Kimpinski,et al.  Neurite growth promotion by nerve growth factor and insulin‐like growth factor‐1 in cultured adult sensory neurons: Role of phosphoinositide 3‐kinase and mitogen activated protein kinase , 2001, Journal of neuroscience research.

[98]  M. Baldwin,et al.  Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4. , 2001, The Journal of endocrinology.

[99]  M. Westwood,et al.  Regulation of IGF bioavailability in pregnancy. , 2001, Molecular human reproduction.

[100]  R. Baxter,et al.  Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit* , 2000, The Journal of Biological Chemistry.

[101]  C. Mantzoros,et al.  Insulin‐like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men , 2000, International journal of cancer.

[102]  L. Murphy.  Overexpression of insulin-like growth factor binding protein-1 in transgenic mice , 2000, Pediatric Nephrology.

[103]  T. Nam,et al.  Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. , 2000, Endocrinology.

[104]  C. Cheng,et al.  Neurotrophins and other growth factors in the regenerative milieu of proximal nerve stump tips , 2000, Journal of anatomy.

[105]  R. Baxter,et al.  A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit. , 2000, Endocrinology.

[106]  R. Baxter,et al.  A Central Domain Binding Site in Insulin-Like Growth Factor Binding Protein-5 for the Acid-Labile Subunit. , 2000, Endocrinology.

[107]  D. Powell,et al.  Insulin-like Growth Factor-binding Protein-3 Binds Fibrinogen and Fibrin* , 1999, The Journal of Biological Chemistry.

[108]  G. Werther,et al.  Basic fibroblast growth factor induces proteolysis of secreted and cell membrane-associated insulin-like growth factor binding protein-2 in human neuroblastoma cells. , 1999, Endocrinology.

[109]  H. Orskov,et al.  The pharmacokinetics of free insulin-like growth factor-I in healthy subjects. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[110]  L. Bach,et al.  HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6. , 1999, American journal of physiology. Endocrinology and metabolism.

[111]  R. Baxter,et al.  Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. , 1999, The Journal of endocrinology.

[112]  L. Bach.  Insulin-Like Growth Factor Binding Protein-6: The “Forgotten” Binding Protein? , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[113]  C. Renner,et al.  Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions , 1998, The EMBO journal.

[114]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein 5 Complexes with the Acid-labile Subunit , 1998, The Journal of Biological Chemistry.

[115]  S. Mohan,et al.  Structure-Function Analysis of the Human Insulin-like Growth Factor Binding Protein-4* , 1998, The Journal of Biological Chemistry.

[116]  D. Powell,et al.  Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3. , 1998, American journal of physiology. Endocrinology and metabolism.

[117]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[118]  J. Guevara-Aguirre,et al.  Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population. , 1998, The Journal of clinical endocrinology and metabolism.

[119]  M. Iwashita,et al.  Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. , 1998 .

[120]  R. Baxter,et al.  Structural Determinants of Ligand and Cell Surface Binding of Insulin-like Growth Factor-binding Protein-3* , 1998, The Journal of Biological Chemistry.

[121]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[122]  G. Werther,et al.  Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. , 1997, Endocrinology.

[123]  T. Nam,et al.  Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. , 1997, Endocrinology.

[124]  R. Baxter,et al.  Phosphorylation of insulin-like growth factor binding proteins , 1997, Molecular and Cellular Endocrinology.

[125]  E. Feldman,et al.  Tyrosine Phosphorylation of Paxillin and Focal Adhesion Kinase during Insulin-like Growth Factor-I-stimulated Lamellipodial Advance* , 1997, The Journal of Biological Chemistry.

[126]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[127]  P. Cohen,et al.  7S nerve growth factor is an insulin-like growth factor-binding protein protease. , 1996, Endocrinology.

[128]  M. Binoux,et al.  Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). , 1995, Endocrinology.

[129]  E. Froesch,et al.  Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. , 1995, Biochemical and biophysical research communications.

[130]  J. Weiler,et al.  IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. , 1995, Growth regulation.

[131]  E. Bonte,et al.  Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. , 1995, The Journal of endocrinology.

[132]  R. Norton,et al.  Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions. , 1995, Journal of molecular biology.

[133]  V. Mukku,et al.  Identification of the major sites of phosphorylation in IGF binding protein‐3 , 1994, Journal of cellular biochemistry.

[134]  T. Nam,et al.  Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. , 1994, Endocrinology.

[135]  J. Bass,et al.  Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins. , 1994, Journal of molecular endocrinology.

[136]  B. Yusta,et al.  Expression of insulin-like growth factor-I (IGF-I) receptor gene in rat brain and liver during development and in regenerating adult rat liver. , 1994, Molecular and cellular endocrinology.

[137]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[138]  R. Koistinen,et al.  Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[139]  M. Rechler,et al.  Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. , 1993, The Journal of biological chemistry.

[140]  D. Clemmons,et al.  Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.

[141]  R. Rosenfeld,et al.  Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. , 1993, Endocrinology.

[142]  D. Clemmons,et al.  Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. , 1993, The Journal of biological chemistry.

[143]  M. Rechler.  Insulin-like growth factor binding proteins. , 1993, Vitamins and hormones.

[144]  M. Carson,et al.  Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. , 1993, Neuron.

[145]  L. Giudice,et al.  Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. , 1992, The Journal of clinical endocrinology and metabolism.

[146]  T. Wood,et al.  Insulin-like growth factor I and II and insulin-like growth factor binding protein-2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs. , 1992, Developmental biology.

[147]  M. Mulholland,et al.  Stimulation of myenteric plexus neurite outgrowth by insulin and insulin-like growth factors I and II. , 1992, Life sciences.

[148]  C. Conover,et al.  Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. , 1991, Endocrinology.

[149]  N. Ling,et al.  Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. , 1991, The Journal of biological chemistry.

[150]  F. Masiarz,et al.  Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum. , 1991, The Journal of biological chemistry.

[151]  D. Styne,et al.  Insulin-like growth factors (IGFs) and IGF-binding proteins in the developing rhesus monkey. , 1991, The Journal of clinical endocrinology and metabolism.

[152]  E. Van Obberghen,et al.  Expression of IGF‐I and insulin receptor genes in the rat central nervous system: A developmental, regional, and cellular analysis , 1991, Journal of neuroscience research.

[153]  V. Sara,et al.  Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. , 1991, Development.

[154]  J. Pintar,et al.  Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. , 1990, Development.

[155]  T. Wood,et al.  The expression pattern of an insulin-like growth factor (IGF)-binding protein gene is distinct from IGF-II in the midgestational rat embryo. , 1990, Molecular endocrinology.

[156]  H. Nagasawa,et al.  Molecular cloning of the Bombyx mori prothoracicotropic hormone. , 1990, Science.

[157]  R. Baxter,et al.  Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. , 1990, The Journal of biological chemistry.

[158]  G. Lundborg,et al.  Insulin-like growth factor I promotes nerve regeneration: an experimental study on rat sciatic nerve. , 1990, Growth factors.

[159]  M. Meister,et al.  cDNAs from neurosecretory cells of brains of Locusta migratoria (Insecta, Orthoptera) encoding a novel member of the superfamily of insulins. , 1990, European journal of biochemistry.

[160]  E. Froesch,et al.  Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. , 1989, Acta endocrinologica.

[161]  Christopher C. Binkert,et al.  Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2). , 1989, The EMBO journal.

[162]  A. Cardin,et al.  Molecular Modeling of Protein‐Glycosaminoglycan Interactions , 1989, Arteriosclerosis.

[163]  R. Palmiter,et al.  Growth enhancement of transgenic mice expressing human insulin-like growth factor I. , 1988, Endocrinology.

[164]  J. Pintar,et al.  Pattern of the insulin-like growth factor II gene expression during rat embryogenesis. , 1988, Development.

[165]  J. Milbrandt,et al.  Differential expression of insulin-like growth factor genes in rat central nervous system. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[166]  R. Baxter,et al.  Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. , 1987, The Journal of clinical endocrinology and metabolism.

[167]  R. Baxter,et al.  Insulin-like growth factor-binding protein from human plasma. Purification and characterization. , 1986, The Journal of biological chemistry.

[168]  M. Bothwell.  Insulin and somatemedin MSA promote nerve growth factor‐independent neurite formation by cultured chick dorsal root ganglionic sensory neurons , 1982, Journal of neuroscience research.

[169]  E. Rinderknecht,et al.  Primary structure of human insulin‐like growth factor II , 1978, FEBS letters.

[170]  E. Rinderknecht,et al.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. , 1978, The Journal of biological chemistry.